MDT: Medtronic plc Company Profile & Statistics

About

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Info & Links

CEO

Geoffrey S. Martha

Headquarters

20 ON HATCH, LOWER HATCH STREET
DUBLIN, L2 D02, IRELAND

Auditor

PricewaterhouseCoopers LLP

Share holders

20,132

Employees

95,000

Medtronic plc Statistics

Valuation Measures

Market Capitalization²

115.41B

Enterprise Value

142.34B

Enterprise Value/EBITDA(ttm)

17.68

Price to Earnings Ratio(ttm)

16.47

Price to Sales(ttm)

3.40

Price to Book(mrq)

2.27

Price to Cash(ytd)

12.21

Profitability

Gross Margin(ttm)

65.05%

Operating Margin(ttm)

20.87%

Profit Margin(ttm)

13.06%

Return on Equity(ttm)

14.07%

Return on Invested Capital(ttm)

5.79%

Return on Assets(ttm)

7.70%

Income Statement

Revenue(ttm)

33.00B

Revenue Per Share(ttm)

25.73

Gross Profit(ttm)

21.46B

EBITDA(ttm)³

8.05B

Net Income Available to Common(ttm)

4.29B

Diluted EPS(ttm)

3.29

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

2.37%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

1.28B

Dividend Yield

3.18%

Float⁴

1.28B

% Held by Insiders

0.20%

% Held by Institutions

82.06%

Balance Sheet

Total Cash(mrq)

7.99B

Total Cash Per Share(mrq)

6.23

Total Debt(mrq)

28.33B

Total Debt/Equity(mrq)

58.15%

Current Ratio(mrq)

1.84%

Quick Ratio(mrq)

1.39%

Book Value Per Share(mrq)

37.98

Cash Flow

Operating Cash Flow Per Share(ytd)

1.51

Free Cash Flow(ytd)

1.02B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MDT

Medtronic plc

Medtronic plc Profile